FOLLOW US

  • facebook
  • twitter
Sun

March 22, 2026

Air Astana $962M IPO

America January 29, 2024

Air Astana $962M IPO Valuation Amidst LSE Drought

Air Astana, the premier airline of Kazakhstan, has unveiled plans for its highly anticipated initial public offering (IPO), aiming to…

By Rihem Akkouche

Hong Kong Court Orders China Evergrande Liquidated

America January 29, 2024

Hong Kong Court Orders China Evergrande Liquidated

In a groundbreaking ruling that could send shockwaves through China’s financial realm, a Hong Kong court has decreed the liquidation…

By Rihem Akkouche

Stricter SEC Rules Raise The Bar For SPAC Offerings

America January 24, 2024

Stricter SEC Rules Raise The Bar For SPAC Offerings

In a decisive 3-2 vote along party lines, the U.S. Securities and Exchange Commission (SEC) has unveiled stringent measures to…

By Rihem Akkouche

Air Astanas $120M London IPO

America January 12, 2024

Air Astana’s $120M London IPO : Propel Growth and Global Reach

Air Astana, Kazakhstan’s premier airline, is set to soar into the London Stock Exchange (LSE) skies with a groundbreaking $120…

By Rihem Akkouche

Investment Co To Block KKRs £1.3B Smart Meter Deal

America December 21, 2023

Investment Co To Block KKR’s £1.3B Smart Meter Deal

In a dramatic turn of events, PrimeStone Capital LLP, an investment company led by Alan Foy and Steve Timoney, has…

By Rihem Akkouche

B.P Marsh £48M Sale Of Broker To Rival Insurer

America December 7, 2023

B.P Marsh £48M Sale Of Broker To Rival Insurer

In a chess-like strategy, B.P. Marsh, a notable U.K. private equity firm, is orchestrating a significant return on its investment.…

By Rihem Akkouche

WeWork Shares Suspended Amid 'Pending' Announcement Speculation

America November 6, 2023

WeWork Bankruptcy? Shares Suspended Amid ‘Pending’ Announcement Speculation

In a move that has left financial markets abuzz with intrigue, shares of WeWork Inc. faced an abrupt suspension of…

By Rochdi Rais

Paul Hastings Manages IPO

America November 3, 2023

Paul Hastings Manages IPO for Lexeo Therapeutics: A Genetic Medicine Game-Changer

In a heart-pounding financial feat, Lexeo Therapeutics Inc., a trailblazing gene-therapy focused biotechnology firm, has unleashed a torrent of excitement…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter